In vivo performance of decellularized tracheal grafts in the reconstruction of long length tracheal defects: Experimental study.

BACKGROUND: The repair of long-segment tracheal lesions remains an important challenge. Nowdays no predictable and dependable substitute has been found. Decellularized tracheal scaffolds have shown to be a promising graft for tracheal transplantation, since it is non-immunogenic. OBJECTIVE: Evaluate in vivo decellularized tracheal allografts performance to replace long tracheal segment. METHODS: Forty-five swines underwent surgery as follows: Fifteen trachea donors and 30 receptors of decellularized trachea allografts. The receptors were randomly divided in five groups (n = 6). In groups I and II, donor trachea segment was decellularized by 15 cycles with sodium deoxycholate and deoxyribonuclease, in group II, the allograft was reinforced with external surgical steel wire. Groups, III, IV, and V decellularization was reduced to seven cycles, supplemented with cryopreservation in group IV and with glutaraldehyde in group V. A 10 rings segment was excised from the receptor swine and the decellularized trachea graft was implanted to re-establish trachea continuity. RESULTS: Both decellularization cycles caused decreased stiffness. All trachea receptors underwent euthanasia before the third post-implant week due to severe dyspnea and trachea graft stenosis, necrosis, edema, inflammation, hemorrhage, and granulation tissue formation in anastomotic sites. Histologically all showed total loss of epithelium, separation of collagen fibers, and alterations in staining. CONCLUSIONS: Both decellularization techniques severely damaged the structure of the trachea and the extracellular matrix of the cartilage, resulting in a no functional graft, in spite of the use of surgical wire, cryopreservation or glutaraldehyde treatment. An important drawback was the formation of fibrotic stenosis in both anastomosis.

Experimental Tracheal Replacement: Angiogenesis and Null Apoptosis Promote Stenosis.

BACKGROUND: Tracheal replacement is a challenge for thoracic surgeons due to stenosis in the trachea-prosthesis anastomosis. We propose that stenosis occurs due to fibrosis as a result of an abnormal healing process, characterized by an increased expression of wound healing growth factors (vascular endothelial growth factor [VEGF], survivin, and CD31), which promote angiogenesis and decrease apoptosis. We analyzed the immunoreactivity of VEGF, survivin, CD31, and caspase-3 in the development of fibrotic stenosis in prosthetic tracheal replacement. METHODS: Fourteen dogs were operated on: group I (n=7) received a 6-ring cervical tracheal segment autograft, while in group II (n=7), a 6-ring segment of the cervical trachea was resected and tracheal continuity was restored with a Dacron prosthesis. The follow-up was 3 months. Immunoreactivity studies for VEGF, survivin, CD31, and caspase-3 were performed. A statistical analysis was done using the Wilcoxon signed rank test. RESULTS: Four animals in group I were euthanized on the 10th postoperative day due to autograft necrosis. Three animals completed the study without anastomotic stenosis. Moderate expression of VEGF (p=0.038), survivin (p=0.038), and CD31 (p=0.038) was found. All group II animals developed stenosis in the trachea-prosthesis anastomotic sites. Microscopy showed abundant collagen and neovascularization vessels. Statistically significant immunoreactive expression of VEGF (p=0.015), survivin (p=0.017), and CD31 (p=0.011) was observed. No expression of caspase-3 was found. CONCLUSION: We found a strong correlation between fibrosis in trachea-prosthesis anastomoses and excessive angiogenesis, moderate to intense VEGF, CD31, and survivin expression, and null apoptotic activity. These factors led to uncontrolled collagen production.

Spontaneous pneumomediastinum in COVID-19 patients. Case series.

Spontaneous pneumomediastinum is defined as the presence of free air within the mediastinum without an apparent cause such as chest trauma. It is a benign, self-limiting condition that is conservatively treated. Clinical diagnosis is based on two symptoms: chest pain and dyspnea; and on a particular sign: subcutaneous emphysema. It has been reported in patients with influenza A (H1N1) and severe acute respiratory syndrome; however, it has been rarely observed in COVID-19 patients. In this work, we describe six male patients with COVID-19, aged between 27 and 82 years, who presented with spontaneous pneumomediastinum and subcutaneous emphysema; both conditions were completely resorbed with conservative management.

El neumomediastino espontáneo es la presencia de aire libre en el mediastino sin el antecedente de alguna causa como trauma de tórax. Es una condición benigna autolimitada que se trata en forma conservadora. El diagnóstico clínico se basa en dos síntomas: dolor torácico y disnea; y en un signo en particular: enfisema subcutáneo. Ha sido reportado en pacientes con influenza A (H1N1) y síndrome respiratorio agudo grave; sin embargo, ha sido raramente observado en pacientes con COVID-19. En este trabajo describimos seis pacientes del sexo masculino con COVID-19, con edades entre 27 y 82 años, que presentaron neumomediastino espontáneo y enfisema subcutáneo; ambos se reabsorbieron totalmente con manejo conservador.

Neumomediastino espontáneo en pacientes COVID-19. Serie de casos / Spontaneous pneumomediastinum in COVID-19 patients. Case series

Resumen El neumomediastino espontáneo es la presencia de aire libre en el mediastino sin el antecedente de alguna causa como trauma de tórax. Es una condición benigna autolimitada que se trata en forma conservadora. El diagnóstico clínico se basa en dos síntomas: dolor torácico y disnea; y en un signo en particular: enfisema subcutáneo. Ha sido reportado en pacientes con influenza A (H1N1) y síndrome respiratorio agudo grave; sin embargo, ha sido raramente observado en pacientes con COVID-19. En este trabajo describimos seis pacientes del sexo masculino con COVID-19, con edades entre 27 y 82 años, que presentaron neumomediastino espontáneo y enfisema subcutáneo; ambos se reabsorbieron totalmente con manejo conservador.

Abstract Spontaneous pneumomediastinum is defined as the presence of free air within the mediastinum without an apparent cause such as chest trauma. It is a benign, self-limiting condition that is conservatively treated. Clinical diagnosis is based on two symptoms: chest pain and dyspnea; and on a particular sign: subcutaneous emphysema. It has been reported in patients with influenza A (H1N1) and severe acute respiratory syndrome; however, it has been rarely observed in COVID-19 patients. In this work, we describe six male patients with COVID-19, aged between 27 and 82 years, who presented with spontaneous pneumomediastinum and subcutaneous emphysema; both conditions were completely resorbed with conservative management.

The Role of ADAR1 and ADAR2 in the Regulation of miRNA-21 in Idiopathic Pulmonary Fibrosis.

INTRODUCTION: microRNAs (miRNAs) are small non-coding 1RNAs that post-transcriptionally regulate gene expression. Recent evidence shows that adenosine deaminases that act on RNA (ADAR) can edit miRNAs. miRNAs are involved in the development of different diseases, such as idiopathic pulmonary fibrosis (IPF). In IPF, about 40% of the miRNAs are differentially expressed with respect to controls. Among these miRNAs, miRNA-21 has been found over-expressed in IPF and its targets are anti-fibrosing molecules such as PELI1 and SPRY2. The objective of this study is to determine the role of ADAR1 and 2 on the expression of miRNA-21 in human lung fibroblasts trough quantification of gene expression, protein levels, and overexpression of ADAR1 and 2. METHODS: Six control and six fibrotic primary fibroblast cell cultures were used for RNA extraction, ADAR1, ADAR2, PELI1, SPRY2, miRNA-21, and pri-miRNA-21 expression was measured. Subsequently, two fibrotic fibroblast cultures were used for overexpression of ADAR1 and ADAR2, and they were stimulated with TGFß1. Real-time PCR and Western blot were performed. RESULTS: ADAR1 is significantly downregulated in IPF fibroblasts; the overexpression of ADAR1 and ADAR2 reestablishes the expression levels of miRNA-21, PELI1, and SPRY2 in fibroblasts of patients with IPF. CONCLUSION: These changes in the processing of miRNAs have great value in pathology diagnosis, including lung diseases, and play an important role in the understanding of molecular mechanisms involved in the development of different pathologies, as well as representing new therapeutic targets.

Lung necrosectomy in pediatric patients with necrotizing pneumonia.

INTRODUCTION: Necrotizing pneumonia is the consolidation of lung parenchyma with destruction and necrosis, forming solitary or multiloculated radiolucent foci. When antibiotic treatment fails and clinical course does not improve, patients might need lung tissue resection: segmentectomy, lobectomy or bilobectomy. We have performed a more conservative surgical approach in pediatric patients with necrotizing pneumonia, lung necrosectomy: resection of unviable necrotic tissue, to preserve more healthy and potentially recoverable lung parenchyma. The objective of this study is to present the results of our experience with lung necrosectomy. METHODS: Retrospective review of clinical charts of children with necrotizing pneumonia. The diagnosis was based on physical examination, laboratory data and contrast CT scan. Lung necrosectomy technique includes resection of necrotic tissue with careful debridement technique; air leaks were sutured and/or tissue imbrication. RESULTS: Twenty-four children were surgically treated for necrotizing pneumonia (18 girls and 6 boys). The mean age was 31.5 ± 13.5 months. All the patients presented productive cough, fever and dyspnea; chest X-rays showed consolidated areas with intraparenchymal cavities and hypoperfusion on the contrasted CT. Surgical treatment included: Lung necrosectomy 17 (70%); lobectomy 3 (12.5%); wedge resection 2 (8.3%); lobectomy + lung necrosectomy 1 (4.1%), and wedge resection + lung necrosectomy 1 (4.1%). The postoperative course was uneventful in 23 patients; mean postoperative hospital stay was 6.3. One patient died because of sepsis. CONCLUSIONS: Lung necrosectomy is a conservative, effective surgical treatment, which solves lung necrotizing infection avoiding resection of healthy lung parenchyma.

Surgical Skills Training with Cryopreserved Rat Stomachs.

The objective of this study is to present a high-fidelity bench model of cryopreserved stomachs that can be used while learning surgical skills. Thirty stomachs were harvested from Wistar rats at the end of non-abdominal research studies. The stomachs were washed with cold saline solution and filled with hyaluronic acid solution. The organs were then placed into cryovials and cryopreserved at -30 °C for 60 days. The stomachs were thawed to room temperature on the day of the surgical skills practice and two full-thickness incisions were made. Reporting on their experiences, 22 participants (73.33%) felt that the cryopreserved stomach was identical to in vivo rat stomachs, 24 (80.00%) reported that the stomach was easy to handle, and 27 (90%) reported the tissue was non-friable. Moreover, 29 participants (96.6%) finished the suturing without tears and 100% recommended it as a biomaterial for surgical training. The cryopreserved stomach is a practical, reproducible, low-cost, and high-fidelity bench model that allows surgical fellows to learn how to handle a stomach and improve their surgical abilities before performing surgery on patients or laboratory animals.

Canine tracheal cartilage cryopreservation: freezing injury is not related to caspase-3 expression.

Currently, there are no surgical strategies to treat tracheal lesions longer than 7 cm. Such patients are not candidates for tracheal resection or end-to-end anastomosis and are thus left with only repeated palliative procedures to relieve their respiratory insufficiency. Experimental studies using cryopreserved trachea have produced contradictory results, limiting the clinical application of this technique. We evaluated caspase-3 expression and the histological integrity of canine tracheal cartilage cryopreserved using two different solutions, two temperatures, and varying lengths of storage time. Thirty canine tracheal segments of 5 rings were studied. Group 1: Control without cryopreservation. Groups 2 and 4: Cryopreserved in F12K media with 20% fetal bovine serum (FBS) at -70°C for 48 hours. Groups 3 and 5: Cryopreserved in 90% FBS at -70°C for 48 hours. Groups 4 and 5 were then stored for 15 days in liquid nitrogen. All of the segments were thawed, fixed in wax, and cut into rings. Three rings were selected for caspase-3 expression and histological evaluation. Staining of cartilage matrices was significantly modified in the tracheal segments of Group 5. The central region of the cartilage ring was more vulnerable to the effects of freezing than the edges. Under the same cryopreservation temperature and storage time, tracheal cartilage integrity is better preserved when F12K media is used. Caspase-3 expression is not related to cartilage injury from the cryopreservation process.

Cryopreserved tracheal segments: a new tool for bench surgical training in thoracic surgery.

PURPOSE: To present a new low-cost high fidelity bench model of cryopreserved trachea that can be used to learn surgical skills from medical students to cardiothoracic surgery fellows. METHODS: Ten tracheas were harvested from ten non-trachea related research dogs at the moment of euthanasia. Each trachea was trimmed in six or seven rings segments. They were cryopreserved and stored during 60 days. The day programmed for surgical skills practice, they were thawed to room temperature. RESULTS: Forty segments have been used. After defrosting, all the segments kept their normal anatomic shape and structural integrity. Two incisions were made on every tracheal segment and sutured with running or separate stitches with 5-0 polypropilene. There were no complications such as cartilage ruptures, neither tears on the mucosae, the cartilages nor the membranous posterior membrane. CONCLUSIONS: The cryopreserved trachea is a high fidelity, practical, reproducible, portable, low-cost bench model. It allows cardiothoracic fellows to learn how to handle a trachea, as well as to perfect their surgical and suture abilities before applying them on a real patient's trachea.

Cryopreserved tracheal segments: a new tool for bench surgical training in thoracic surgery / Segmentos criopreservados de traqueia: uma nova ferramenta para auxiliar o treinamento na cirurgia torácica

PURPOSE: To present a new low-cost high fidelity bench model of cryopreserved trachea that can be used to learn surgical skills from medical students to cardiothoracic surgery fellows. METHODS: Ten tracheas were harvested from ten non-trachea related research dogs at the moment of euthanasia. Each trachea was trimmed in six or seven rings segments. They were cryopreserved and stored during 60 days. The day programmed for surgical skills practice, they were thawed to room temperature. RESULTS: Forty segments have been used. After defrosting, all the segments kept their normal anatomic shape and structural integrity. Two incisions were made on every tracheal segment and sutured with running or separate stitches with 5-0 polypropilene. There were no complications such as cartilage ruptures, neither tears on the mucosae, the cartilages nor the membranous posterior membrane. CONCLUSIONS: The cryopreserved trachea is a high fidelity, practical, reproducible, portable, low-cost bench model. It allows cardiothoracic fellows to learn how to handle a trachea, as well as to perfect their surgical and suture abilities before applying them on a real patient's trachea.

OBJETIVO: Apresentar novo modelo de traquéia criopreservada de baixo custo e alta fidelidade que pode ser usado tanto por estudantes de medicina como por cirurgiões cardiotorácicos no aprendizado e desenvolvimento de suas habilidades cirúrgicas. MÉTODOS: Foram coletados amostras de dez traquéias de dez cães utilizados para pesquisa após a eutanásia. Cada segmento de traquéia foi dividida em seis ou sete anéis, criopreservadas e armazenadas durante 60 dias. No dia programado para a prática cirúrgica os segmentos foram descongelados a temperatura ambiente. RESULTADOS: Foram utilizados 40 segmentos no estudo. Após o descongelamento todos os segmentos mantiveram sua forma anatômica e sua integridade estrutural. Foram realizadas duas incisões em cada segmento traqueal que foram suturadas em padrão continuo ou com pontos separados utilizando sutura de polipropileno 5-0. Não houve nenhuma complicação como a ruptura da cartilagem, rasgos na mucosa, cartilagem ou na membrana membranosa posterior. CONCLUSÕES: O modelo de traquéia criopreservada é altamente fidedigno, prático, reproduzível, portátil e de baixo custo. Permite que os cirurgiões cardiotorácicos aprendam como manipular a traquéia, assim como aperfeiçoar suas habilidades cirúrgicas antes de sua aplicação em traquéias de pacientes reais.

Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure.

A variety of patch materials has been used to close large atrial septal defects (ASD). Autologous pericardium and glutaraldehyde-preserved bovine pericardium are the most used. Lyophilized bovine pericardium has not been tested inside the cardiovascular system. The aim of this work was to study the behaviour and effectiveness of lyophilized glutaraldehyde-preserved bovine pericardium in ASD closure. Sixteen mongrel dogs were operated on. A 3 cm diameter atrial septal defect was created, and closed with: Group I (n=8): Lyophilized glutaraldehyde preserved bovine pericardium (LGPBP). Group II (n=8): Vascular Dacron patch. The animals were evaluated clinically, by echocardiography, macroscopically, and microscopically. Statistical analysis was done with analysis of variance (ANOVA) and Student's t-test. All the animals survived the surgical procedure and study time (6 months). Clinically all the animals displayed normal physical activity, with normal cardiac sounds. Echocardiography showed that both groups had a normal heart without intracardiac shunts, no thrombus formation, and no vegetations. Macroscopically all the animals showed good integration of the lyophilized bioprosthesis and Dacron patch. All group I animals presented a decrease of the area of the ASD in the left atrium (p<0.001 by ANOVA and Student's t-test). Microscopically, group I presented dense and well-organized collagenous tissue, areas of cartilaginous metaplasia and remnants of the lyophilized bioprosthesis (p<0.001 by ANOVA and Student's t-test). Group II showed encapsulated Dacron patch covered with collagenous tissue and cartilaginous metaplasia. In conclusion, the new lyophilized bioprosthesis is well integrated into the atrial septum, without complications and is effective for ASD closure.

Wound healing modulators in a tracheoplasty canine model.

Postsurgical tracheal stenosis results from fibrosis formation due to ischemia. There are healing modulators, hyaluronic acid (HA) and collagen polyvinylpyrrolidone (CPVP), which reduce collagen fibers formation. Thus we can hypothesize that the topical application of one of these modulators can diminish postsurgical tracheal scarring and stenosis. The aim of this work was to evaluate the macroscopic, microscopic, and biochemical changes of tracheal healing after the application of HA or CPVP in a canine tracheoplasty model. The study design was prospective experimental investigation in a canine model. Eighteen mongrel dogs underwent three cervical tracheal rings resection and end-to-end anastomosis. They were randomized into three groups according to treatment: group I (control group) (n = 6), topical application of saline solution on tracheal anastomosis; group II (n = 6), topical application of 15 microg HA on tracheal anastomosis; and group III (n = 6), topical application of 2.5 mg CPVP on tracheal anastomosis. They were evaluated clinical, radiological and tracheoscopically during 4 weeks. They were euthanized at the end of the study time. Macroscopic, microscopic, and biochemical changes of tracheal anastomosis healing were analyzed. Collagen formation was quantified by the Woessner method. All the animals survived the surgical procedure and study period. Macroscopic, radiologic, and endoscopic studies showed that animals in group I developed tracheal stenosis, inflammation, and firm fibrous tissue formation, and histological studies also showed severe inflammatory reaction and fibrosis formation. Groups II (HA) and III (CPVP) showed well-organized thin collagen fibers with minimal inflammatory response. Biochemical evaluation revealed a higher collagen concentration in group I animals (analysis of variance [ANOVA] p < .05 and Tukey p < .01). Thus, hyaluronic acid or collagen polyvinylpyrrolidone administered after tracheal anastomosis diminished the degree of stenosis and inflammatory reaction. Both modulators improved tracheal healing.

Trasplante experimental de tráquea cervical combinado con la aplicación de factor de crecimiento de fibroblastos / Experimental cervical trachea transplant combined with application of basic fibroblast growth factor

Antecedentes: El trasplante traqueal de longitudes mayores a 6 cm de longitud ha fallado por complicaciones isquémicas del injerto. Experimenta/mente se han utilizado factores de crecimiento y diferentes técnicas quirúrgicas, como la de trasplante traqueal dividido para favorecer la neoformación de vasos sanguíneos. Objetivo: Evaluar la viabilidad, cambios tráquea cervical, macroscópicos y microscópicos del trasplante de tráquea cervical en perros al utilizar la técnica quirúrgica de trasplante traqueal dividido, combinando la aplicación del factor básico de crecimiento para fibroblastos en los sitios de las anastomosis. Material y métodos: Se operaron 24 perros que fueron divididos en 4 grupos de estudio: Grupo I (n = 6): Trasplante de 9 anillos de tráquea cervical con la técnica convencional (TTCC); Grupo II (n = 6): TTCC e instilación tópica de factor básico de crecimiento de fibroblastos (bFGF) en los sitios de anastomosis; Grupo III (n = 6): Trasplante con la técnica de trasplante dividido (TTCD) y Grupo IV (n = 6): TTCD y aplicación de bFGF. Los animales recibieron triple inmunosupresión (azatioprina, metilprednisolona, ciclos-porína). Se planearon evaluaciones clínica, radiológica y traqueoscópica durante 4 semanas. Al final del estudio los injertos trasplantados se evaluaron macroscópica y microscópicamente. Resultados: Ningún animal concluyó su tiempo de estudio por disnea grave durante la primera semana del estudio. Macroscópicamente todos los injertos desarrollaron fístulas y necrosis. Microscópicamente mostraron necrosis, inflamación, vasculitis, hemorragia y destrucción del cartílago. Conclusión: En este estudio encontramos que el trasplante de tráquea cervical mayor a 6 cm, tiene malos resultados con la técnica quirúrgica convencional o dividida e inmunosupresión, así como con y sin la aplicación de bFGF en los sitios de anastomosis.

Background: Tracheal transplantation of lesions larger than 6 cm fails due to ischemic complications. Growth factors and different surgical techniques, including the divided tracheal graft technique, have been used experimentally to stimulate the neoformation of blood vessels. Objective: Assessment of the viability and macroscopic and microscopic changes of the cervical transplanted trachea in dogs, using the divided tracheal graft technique, combined with the application of basic fibroblast growth factor (bFGF) on the anastomotic site. Material and methods: Twenty four mongrel dogs were divided in 4 study groups: Group I (n = 6): Transplantation of 9 cervical tracheal rings with the conventional surgical technique (TCTC). Group II (n = 6): TCTC combined with topical instillation of bFGF at on the anastomotic line. Group III (n = 6): Transplantation of cervical trachea using the divided tracheal graft technique (TCTD), and Group IV (n = 6): TCTD with topical application of bFGF. The animals received triple immunotherapy (azathioprine, methylprednisolone, cyclosporine) and were to have clinical, radiological and endoscopical evaluation during 4 weeks. At the end of the study, macroscopic and microscopic evaluations of the transplanted grafts were done. Results: No animal completed the study time due to severe dyspnea during the first postoperative week. Macroscopically all grafts showed necrosis and fistulae formation. Microscopically we observed necrosis, inflammation, vasculitis, hemorrhage and destruction of cartilage in all the grafts. Conclusion: In this study, tracheal allotransplanta-tion longer than 6 cm with either surgical technique, with immunosuppression, with or without bFGF, is unsuccessful.

Uso del pericardio bovino tratado con glutaraldehído / Use of glutaraldehide-treated bovine pericardium

El uso de las prótesis mecánicas y biológicas surgió de la necesidad de reemplazar quirúrgicamente la falta o la falla de un órgano. Las bioprótesis están hechas a partir de tejido autólogo, homólogo y heterólogo. La bioprótesis de pericardio bovino tratada con glutaraldehído es la más estudiada y se utiliza principalmente como bioprótesis cardiaca. Debido a su fácil preparación y uso, este material se ha empleado para reparar defectos hemiarios de la pared abdominal, la pared torácica, de diafragma y para sustituir vasos y tráquea; sin embargo, causa reacción de rechazo y tipo cuerpo extraño, los que han sido estudiados ampliamente para evitarlos. Presentamos una revisión de la literatura sobre el uso y estudio de la bioprótesis de pericardio bovino tratado con glutaraldehído.

The use of biological and mechanical prostheses arose from the need to replace a failing organ or function. Bioprostheses can be manufactured from autologous, homologus or heterologus tissue; glutaraldehyde treated bovine pericardium bioprostheses have been used extensively to repair diaphragmatic, abdominal and chest wall defects and to replace heart valves, blood vessels and tracheal segments, but the implanted tissue can elicit rejection or foreign body reaction; these have been extensively studied in order to avoid them. We review the literature regarding glutaraldehyde treated bovine pericardium bioprostheses.

Derivación cavopulmonar bidireccional para la atresia tricuspídea. Experiencia en el Instituto Nacional de Cardiología / Bidirectional cavo-pulmonary shunt in the tricuspid atresia

La derviación cavopulmonar bidireccional surgió como una alternativa paliativa y en ocasiones definitivas para el manejo de pacientes con cardipatías congénitas complejas univentriculares, para aquellos pacientes que no son candidatos "ideales" para ser sometidos a un procedimiento de Fontan. En este trabajo presentamos nuestra experiencia con esta técnica quirúrgica para el tratamiento de los pacientes con atresia tricuspidea. Se operaron 20 pacientes con diagnóstico de atresia tricuspidea y los siguientes defectos asociados: 20 CIA, 17 CIV, 10 EP, 1 AP, 1 TGA. Fueron 10 masculinos y 10 femeninos, con edades de 27 días a 6 años (media 1.8 años), peso de 3.2 kg a 24 kg (media 10.7 kg). La presión media de la arteria pulmonar de 11 a 24 mmHg (media 7 mmHG), la resistencia pulmonar fue de 1.5 a 5 UW (media 3.1UW). La saturación de oxígeno mejoró de un 15 hasta 120 por ciento en el postoperatorio mediato. Todos los pacientes sobrevivieron al procedimiento quirúrgico: tres pacientes fallecieron en el postoperatorio mediato: 2 por complicaciones inherentes al manejo postoperatorio y uno por sepsis. Se presentaron 2 muertes tardías, una paciente falleció de muerte súbita a los 6 meses de procedimiento y el otro falleció por sepsis posterior a la correción total. Se presentaron 4 pacientes con derrame pleural y 2 con derrame pericárdico, los cuales se resolvieron favorablemente. Los 15 pacientes vivos se encuentran estables, en clase funcional I y con cianosis mínima. En conclusión podemos decir que la derivación cavopulmonar bidireccional es un procedimiento quirúrgico útil para el manejo de pacientes con atresia tricuspidea

Substitución valvular mitral con prótesis mecánica de disco: una alternativa quirúrgica / Mitral valve replacement with mechanical disc valve. A surgical alternative

De julio a diciembre de 1993, 10 pacientes fueron sometidos a cambio valvular mitral con prótesis mecánica de disco, y sutura continua, preservando el aparato valvular mitral posterior. Fueron 6 hombres y 4 mujeres, con edad promedio de 44.2 años( 25 a 63 años). Tres pacientes estaban en clase funcional II de la NYHA, 5 en clase funcional III y 2 en clase funcional IV. Se hizo cambio valvular mitral único en 8 pacientes: en 2 fue el primer cambio, en 4 reoperación de segunda vez y en 2 reoperación de tercera vez. En un paciente se hizo doble cambio valvular (mitral y aórtico) con plastía tricuspídea. En otro se efectuó revascularización coronaria con dos injertos venosos, además del cambio valvular mitral. Durante el procedimiento quirúrgico, todos los sujetos fueron sometidos a cirulación extracorpórea, hipotermia moderada a 28 grado centígrados y protección miocárdica con cardioplejía cristaloide fría a 4 grados centígrados con potasio, aplicándose de 1 a 2 dosis. El tiempo promedio de pinzamiento aórtico fue de 37 minutos y el de cirulación extracorpórea de 64 minutos para el cambio valvular mitral único. Con base en los resultados preliminares obtenidos, la alternativa quirúrgica que presentamos es efectiva y segura. Representa menor tiempo de isquemia y de cirulación extracorpórea, preserva el aparato valvular mitral posterior y evita el atrapamiento del disco por material residual o cuerda tendinosas.

Reconstrucción del tracto de salida normal del ventrículo derecho en la operación de Ross / Normal right ventricle outflow tract reconstruction in the Ross operation

En la actualidad existen procedimientos quirúrgicos que requiren la intervención del tracto de salida normal del ventrículo derecho (TSVD) y su posterior reconstrucción. En este trabajo presentamos la antomía quirúrgica de la raíz normal de la arteria pulmonar y su reconstrucción en la operación de Ross en 13 pacientes operados desde febrero de 1992 hasta febrero de 1994. Se efectuó la excisión de la vávula pulmonar y, para mantener la continuidad del ventrículo derecho con la arteria pulmonar (VD-AP) se colocaron, en todos los casos, conducto de pericardio autólogo con una bioprótesis de pericardio bovino del Instituto Nacional de Cardiología (INC), que fueron elaborados durante la cirugía. El postoperatorio fue satisfactorio en todos y su evolución clínica hasta la fecha es adecuada. El seguimiento, con control ecocardiográfico de todos los conductos valvulados, no ha revelado gradientes transpulmonar ni regurgitación. Estamos convencidos de que es muy importante conocer la anatomía quirúrgica de la raíz pulmonar para evitar daño irreversible. Por otro lado, es de gran valor el conocimiento de las diferentes alternativas que hay para reconstruir el TSVD y su evolución a largo plazo.

Colapso circulatorio intraoperatorio debido a espasmo coronario después de revascularización coronaria exitosa / Intraoperative circulatory collapse due to coronary artery spasm folowing successfully coronary artery bypass graftin

Es espasmo de las arterias coronarias es una entidad actualmente reconocida como causa de isquemia y de colapso circulatorio en el trans y post-operatorio de la cirugía de revascularización coronaria. Presentamos nuestra experiencia en la detección y manejo de 2 casos con colapso hemodinámico durante el retiro de la circulación extracorpórea. Estos síntomas fueron refractarios al tratamiento con inotrópicos como la norepinefrina, y la epinefrina y con vasodilatadores como la nitroglicerina. Los cambios electrocardiográficos y la pobre respuesta al tratamiento, en ambos casos, donde la cirugía se consideró exitosa, en base a protección miocárdica excelente y revascularización completa, sugirieron un espasmo coronario severo. En ambos se usó nifedipina sublingual, obteniéndose una respuesta satisfactoria e inmediata, lo que permitió retirar el apoyo inotrópico y la circulación extracorpórea. Revisamos la literatura sobre la fisiopatología y el tratamiento del espasmo coronario en la cirugía cardiaca

Uso de la arteria gastroepiploica derecha para la revascularización del miocardio posterior / The use of the right gastroepiploic artery in the revasculatization of the powterior myocardium

De agosto de 1992 a junio de 1993, se usó la arteria gastroepiploica derecha para revascularizar el miocardio posterior en 8 pacientes. Todos fueron del sexo masculino y las edades fluctuaron entre 32 y 65 años con una media de 51 años. En todos los casos se usó la arteria mamaria interna izquierda, en 3 arteria mamaria interna derecha y en uno la arteria epigástrica inferior derecha como injerto libre para revascularizar otras áreas del miocardio. El número de puentes por paciente fue de tres con un total de 20 injertos arteriales de los cuales 19 fueron con pedículo y solamente uno como injerto libre. El tiempo de pinzamiento aórtico fue de 52 a 80 minutos con una media de 72 minutos. A todos los pacientes se les administró cardioplejía combinada anterógrada/retrógrada por ráiz aórtica y el seno venoso coronario, respectivamente, y ninguno requirió de inotrópicos para soporte ventricular. Las arterias gastroepiploicas para revascularizar el miocardio posterior a diferentes niveles y su vía de paso fue la anterohepática transdiafragmática. No hubo complicaciones inherentes a la técnica ni al uso de la arteria, en el post-operatorio inmediato. La evolución de los pacientes fue satisfactoria en todos los casos: los operados se reportan asintomáticos. Podemos decir, en conclusión, que el uso de la arteria gastroepiploica para revascularizar el miocardio posterior es excelente. No existen dificultades en la técnica ni complicaciones gastrointestinales y estamos incrementando nuestra experiencia con el fin de establecer su uso rutinario

Autotrasplante de la válvula pulmonar para valvulopatía aórtica / Pulmonary autograft replacement of the aortic valve

Se operaron 12 pacientes en forma consecutiva, de febrero de 1992 a junio de 1993, con trasplante de la válvula pulmonar autógena en posición aórtica y reconstrucción del tracto de salida del ventrículo derecho con un tubo valvulado de pericardio autólogo y prótesis de pericardio bovino del Instituto Nacional de Cardiología "Ignacio Chávez". En todos los pacientes se midieron preoperatoriamente los diámetros anulados aórtico y plmonar por ecocardiograma transtorácico. Se efectuó control con ecotransesofágico, en todos, para valorar durante el acto operatorio la función de las válvulas trasplantadas. No hubo morbimortalidad periopertoria y los pacientes no recibieron anticoagulación. La evolución de los pacientes, en general, fue satisfactora y fueron egresados del hospital previó ecocardiograma transtorácico de control. Las medidas de los diámetros anulares se correlacionaron perfectamente con las medidas durante la cirugía. Concluimos que el uso de la válvula pulmonar autógena es beneficioso para resolver el problema de la valvulopatía aórtica en pacientes seleccionados. En nuestro medio, no causa morbimortalidad más importante que el cambio valvular simple